This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vemulapalli, S. Articles by Barnett, A. Search for Related Content PubMed PubMed Citation Articles by Vemulapalli, S. Articles by Barnett, A.

Hypertension, Vol 6, 489-493, Copyright © 1984 by American Heart Association

ARTICLES

Cardiovascular and renal action of platelet-activating factor in anesthetized dogs

S Vemulapalli, PJ Chiu and A Barnett

Platelet-activating factor (PAF) has hypotensive effects similar to those of antihypertensive polar renomedullary lipid (APRL), a potent endogenous hypotensive lipid. In this study the cardiovascular and renal effects of PAF were characterized in anesthetized dogs. Intravenous infusion of PAF at 0.1 micrograms/kg/min for 1 hour caused marked reduction in arterial blood pressure and cardiac output and was accompanied by minimal changes in heart rate. Concomitantly, renal blood flow, glomerular filtration rate, urine flow, and fractional excretion of Na+ and K+ fell significantly. Plasma renin activity was greatly stimulated (11.9 +/- 1.66 vs 3.26 +/- 0.45 ng/angiotensin I/ml/hr for the placebo group). There were no significant alterations in any of these parameters following PAF at a lower dose (0.03 micrograms/kg/min for 1 hour). In a separate study, PAF at 0.1 micrograms/kg/min for 20 minutes produced a decrease in left ventricular myocardial contractile force, concomitant with bradycardia and hypotension, which indicated the presence of a negative inotropic activity. It is concluded that systemic administration of PAF has a deleterious effect on kidney function due to arterial hypotension and diminished cardiac output.

This article has been cited by other articles:

				R. K. Handa, J. W. Strandhoy, C. E. Giammattei, and S. E. Handa Platelet-activating factor and solute transport processes in the kidney Am J Physiol Renal Physiol, February 1, 2003; 284(2): F274 - F281. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				S. G. Greenberg and K. E. Clark Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R996 - R1001. [Abstract] [Full Text] [PDF]